{"id":7531,"date":"2022-06-07T08:05:44","date_gmt":"2022-06-07T08:05:44","guid":{"rendered":"https:\/\/r-biopharm.com\/?p=7531"},"modified":"2022-07-11T12:08:44","modified_gmt":"2022-07-11T12:08:44","slug":"ausdiagnostics-rejoint-le-groupe-r-biopharm","status":"publish","type":"post","link":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/","title":{"rendered":"AusDiagnostics rejoint le Groupe R-Biopharm"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_single_image image=\u00a0\u00bb7486&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][vc_column_text css=\u00a0\u00bb.vc_custom_1654587548868{margin-bottom: 0px !important;}\u00a0\u00bb]\n<h3><strong>Acquisition par R-Biopharm de la soci\u00e9t\u00e9 AusDiagnostics, fabricant australien de mat\u00e9riel de laboratoire et sp\u00e9cialiste en biologie mol\u00e9culaire multiplexe<\/strong><\/h3>\n[\/vc_column_text][vc_column_text css=\u00a0\u00bb.vc_custom_1654587559514{margin-bottom: 0px !important;}\u00a0\u00bb]Conqu\u00e9rir de nouveaux segments de march\u00e9 dans le domaine du diagnostic clinique gr\u00e2ce \u00e0 un positionnement exceptionnel en tant que fournisseur de syst\u00e8mes destin\u00e9s au diagnostic de laboratoire[\/vc_column_text][mk_padding_divider size=\u00a0\u00bb20&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1654587584069{margin-bottom: 0px !important;}\u00a0\u00bb]Darmstadt, 7\u00a0juin 2022 \u2013 R-Biopharm AG, \u00e9minente soci\u00e9t\u00e9 allemande de biotechnologie op\u00e9rant \u00e0 l\u2019\u00e9chelle mondiale, a annonc\u00e9 l\u2019acquisition de AusDiagnostics. R-Biopharm \u00e9toffe sa gamme de produits gr\u00e2ce \u00e0 la reprise de cette soci\u00e9t\u00e9 australienne sp\u00e9cialis\u00e9e dans la fabrication de diagnostics biomol\u00e9culaires multiplexes, de r\u00e9actifs d\u2019extraction et de mat\u00e9riel d\u2019automatisation pour laboratoires. Ce faisant, la soci\u00e9t\u00e9 va conqu\u00e9rir de nouveaux segments de march\u00e9 dans le domaine du diagnostic clinique, poursuivant ainsi sa politique de d\u00e9veloppement \u00e0 l\u2019international. \u00ab\u00a0Avec les plateformes d\u2019analyse biomol\u00e9culaire multiplexe existantes et \u00e0 venir propos\u00e9es par AusDiagnostics pour le d\u00e9pistage de syndromes, nos comp\u00e9tences en biologie mol\u00e9culaire vont augmenter et compl\u00e9ter \u00e0 merveille notre gamme actuelle de dispositifs de diagnostic clinique\u00a0\u00bb, d\u00e9clare Christian Dreher, PDG de R-Biopharm. \u00ab\u00a0Cette acquisition renforce notre position en tant que partenaire de confiance dans le domaine des solutions syst\u00e8me, ce qui nous permet de proposer de nouvelles solutions de diagnostic \u00e0 nos clients.\u00a0\u00bb[\/vc_column_text][vc_single_image image=\u00a0\u00bb7498&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb add_caption=\u00a0\u00bbyes\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][vc_column_text css=\u00a0\u00bb.vc_custom_1657541321932{margin-bottom: 0px !important;}\u00a0\u00bb]D\u00e8s sa cr\u00e9ation en 2006, la soci\u00e9t\u00e9 australienne a lanc\u00e9 sa technologie brevet\u00e9e de PCR multiplexe en tandem (MT-PCR) sur le march\u00e9. Il est actuellement possible de d\u00e9tecter simultan\u00e9ment jusqu\u2019\u00e0 24\u00a0agents pathog\u00e8nes ou g\u00e8nes de r\u00e9sistance \u00e0 partir d\u2019un seul \u00e9chantillon, ce qui permet de r\u00e9duire la dur\u00e9e des proc\u00e9dures de test, que ce soit chez les humains ou les animaux, mais aussi dans le cadre des analyses environnementales, agricoles et alimentaires. Cette plateforme d\u2019analyse est utilis\u00e9e dans des laboratoires et des h\u00f4pitaux du monde entier pour d\u00e9pister un large \u00e9ventail de pathologies.<\/p>\n<p>Scott Gilroy, PDG d\u2019AusDiagnostics, a d\u00e9clar\u00e9 que cette op\u00e9ration marquait un nouveau chapitre passionnant pour l\u2019entreprise\u00a0: \u00ab\u00a0AusDiagnostics et R-Biopharm AG partagent le m\u00eame engagement \u00e0 l\u2019\u00e9gard de l\u2019innovation dans le domaine de la biotechnologie. Cette acquisition va renforcer AusDiagnostics et acc\u00e9l\u00e9rer notre pr\u00e9sence mondiale. Au cours des deux derni\u00e8res ann\u00e9es, notre large gamme de produits innovants, le talent de notre \u00e9quipe et l\u2019incroyable fid\u00e9lit\u00e9 de nos clients nous ont permis de conna\u00eetre une croissance exceptionnelle, qui nous place en t\u00eate du secteur. Rejoindre le groupe R-Biopharm nous permettra de poursuivre sur cette belle lanc\u00e9e et de continuer \u00e0 proposer un service et des produits exceptionnels \u00e0 nos clients australiens et internationaux.\u00a0\u00bb<\/p>\n<p>AusDiagnostics compte actuellement un effectif de 114 personnes et poss\u00e8de des bureaux en Nouvelle-Z\u00e9lande, aux \u00c9tats-Unis et en Grande-Bretagne. Situ\u00e9s en Australie et en Grande-Bretagne, ses sites de production approvisionnent un r\u00e9seau en expansion soutenue de plus de 25 distributeurs et partenaires \u00e0 travers le monde. R-Biopharm esp\u00e8re ainsi b\u00e9n\u00e9ficier de nouvelles synergies pour la production de sa gamme de produits de diagnostic clinique, mais aussi en termes de service et d\u2019assistance au niveau mondial.[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=\u00a0\u00bb7486&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][vc_column_text css=\u00a0\u00bb.vc_custom_1654587548868{margin-bottom: 0px !important;}\u00a0\u00bb] Acquisition par R-Biopharm de la soci\u00e9t\u00e9 AusDiagnostics, fabricant australien de mat\u00e9riel de laboratoire et sp\u00e9cialiste en biologie mol\u00e9culaire multiplexe [\/vc_column_text][vc_column_text css=\u00a0\u00bb.vc_custom_1654587559514{margin-bottom: 0px !important;}\u00a0\u00bb]Conqu\u00e9rir de nouveaux segments de march\u00e9 dans le domaine du diagnostic clinique gr\u00e2ce \u00e0 un positionnement exceptionnel en tant que fournisseur de syst\u00e8mes destin\u00e9s au diagnostic [&hellip;]<\/p>\n","protected":false},"author":1114,"featured_media":7476,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[355],"tags":[],"class_list":["post-7531","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AusDiagnostics rejoint le Groupe R-Biopharm - R-Biopharm AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AusDiagnostics rejoint le Groupe R-Biopharm - R-Biopharm AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_single_image image=\u00a0\u00bb7486&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][vc_column_text css=\u00a0\u00bb.vc_custom_1654587548868{margin-bottom: 0px !important;}\u00a0\u00bb] Acquisition par R-Biopharm de la soci\u00e9t\u00e9 AusDiagnostics, fabricant australien de mat\u00e9riel de laboratoire et sp\u00e9cialiste en biologie mol\u00e9culaire multiplexe [\/vc_column_text][vc_column_text css=\u00a0\u00bb.vc_custom_1654587559514{margin-bottom: 0px !important;}\u00a0\u00bb]Conqu\u00e9rir de nouveaux segments de march\u00e9 dans le domaine du diagnostic clinique gr\u00e2ce \u00e0 un positionnement exceptionnel en tant que fournisseur de syst\u00e8mes destin\u00e9s au diagnostic [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\" \/>\n<meta property=\"og:site_name\" content=\"R-Biopharm AG\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T08:05:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-11T12:08:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1667\" \/>\n\t<meta property=\"og:image:height\" content=\"1667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"niclas\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"niclas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\"},\"author\":{\"name\":\"niclas\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\"},\"headline\":\"AusDiagnostics rejoint le Groupe R-Biopharm\",\"datePublished\":\"2022-06-07T08:05:44+00:00\",\"dateModified\":\"2022-07-11T12:08:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\"},\"wordCount\":621,\"image\":{\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\",\"url\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\",\"name\":\"AusDiagnostics rejoint le Groupe R-Biopharm - R-Biopharm AG\",\"isPartOf\":{\"@id\":\"https:\/\/r-biopharm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg\",\"datePublished\":\"2022-06-07T08:05:44+00:00\",\"dateModified\":\"2022-07-11T12:08:44+00:00\",\"author\":{\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\"},\"breadcrumb\":{\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage\",\"url\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg\",\"contentUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg\",\"width\":1667,\"height\":1667},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/r-biopharm.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AusDiagnostics rejoint le Groupe R-Biopharm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/r-biopharm.com\/#website\",\"url\":\"https:\/\/r-biopharm.com\/\",\"name\":\"R-Biopharm AG\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/r-biopharm.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\",\"name\":\"niclas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"caption\":\"niclas\"},\"url\":\"https:\/\/r-biopharm.com\/fr\/author\/niclas\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AusDiagnostics rejoint le Groupe R-Biopharm - R-Biopharm AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/","og_locale":"fr_FR","og_type":"article","og_title":"AusDiagnostics rejoint le Groupe R-Biopharm - R-Biopharm AG","og_description":"[vc_row][vc_column][vc_single_image image=\u00a0\u00bb7486&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][vc_column_text css=\u00a0\u00bb.vc_custom_1654587548868{margin-bottom: 0px !important;}\u00a0\u00bb] Acquisition par R-Biopharm de la soci\u00e9t\u00e9 AusDiagnostics, fabricant australien de mat\u00e9riel de laboratoire et sp\u00e9cialiste en biologie mol\u00e9culaire multiplexe [\/vc_column_text][vc_column_text css=\u00a0\u00bb.vc_custom_1654587559514{margin-bottom: 0px !important;}\u00a0\u00bb]Conqu\u00e9rir de nouveaux segments de march\u00e9 dans le domaine du diagnostic clinique gr\u00e2ce \u00e0 un positionnement exceptionnel en tant que fournisseur de syst\u00e8mes destin\u00e9s au diagnostic [&hellip;]","og_url":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/","og_site_name":"R-Biopharm AG","article_published_time":"2022-06-07T08:05:44+00:00","article_modified_time":"2022-07-11T12:08:44+00:00","og_image":[{"width":1667,"height":1667,"url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg","type":"image\/jpeg"}],"author":"niclas","twitter_misc":{"\u00c9crit par":"niclas","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#article","isPartOf":{"@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/"},"author":{"name":"niclas","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"headline":"AusDiagnostics rejoint le Groupe R-Biopharm","datePublished":"2022-06-07T08:05:44+00:00","dateModified":"2022-07-11T12:08:44+00:00","mainEntityOfPage":{"@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/"},"wordCount":621,"image":{"@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/","url":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/","name":"AusDiagnostics rejoint le Groupe R-Biopharm - R-Biopharm AG","isPartOf":{"@id":"https:\/\/r-biopharm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage"},"image":{"@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg","datePublished":"2022-06-07T08:05:44+00:00","dateModified":"2022-07-11T12:08:44+00:00","author":{"@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"breadcrumb":{"@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#primaryimage","url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg","contentUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220513_rbio_uebernahme_aus-diagnostics_v04_en_quadrat.jpg","width":1667,"height":1667},{"@type":"BreadcrumbList","@id":"https:\/\/r-biopharm.com\/fr\/ausdiagnostics-rejoint-le-groupe-r-biopharm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r-biopharm.com\/fr\/"},{"@type":"ListItem","position":2,"name":"AusDiagnostics rejoint le Groupe R-Biopharm"}]},{"@type":"WebSite","@id":"https:\/\/r-biopharm.com\/#website","url":"https:\/\/r-biopharm.com\/","name":"R-Biopharm AG","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r-biopharm.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4","name":"niclas","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","caption":"niclas"},"url":"https:\/\/r-biopharm.com\/fr\/author\/niclas\/"}]}},"_links":{"self":[{"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/posts\/7531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/users\/1114"}],"replies":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/comments?post=7531"}],"version-history":[{"count":2,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/posts\/7531\/revisions"}],"predecessor-version":[{"id":7935,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/posts\/7531\/revisions\/7935"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/media\/7476"}],"wp:attachment":[{"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/media?parent=7531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/categories?post=7531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/r-biopharm.com\/fr\/wp-json\/wp\/v2\/tags?post=7531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}